ADAR1 Capital Management, LLC
CIK 1940272 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- RPRX16.61%
- KROS12.24%
- ROIV6.31%
- ABUS3.88%
- CYTK3.44%
- BBIO3.34%
- MACK3.30%
- MRTX2.84%
- MRK2.63%
- ASND2.58%
Share classes counted separately57.17%
Portfolio value by quarter
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | RPRXROYALTY PHARMA PLC- CL ASHS CLASS A View history and evidence | $37.13M | 16.61% | 1.32M shares | Prior unavailable — | — | ↗▾ |
| 02 | KROSKEROS THERAPEUTICS INC View history and evidence | $27.37M | 12.24% | 688.32K shares | Prior unavailable — | — | ↗▾ |
| 03 | ROIVROIVANT SCIENCES LTDSHS View history and evidence | $14.11M | 6.31% | 1.26M shares | Prior unavailable — | — | ↗▾ |
| 04 | ABUSARBUTUS BIOPHARMA CORP View history and evidence | $8.67M | 3.88% | 3.47M shares | Prior unavailable — | — | ↗▾ |
| 05 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $7.69M | 3.44% | 92.08K shares | Prior unavailable — | — | ↗▾ |
| 06 | BBIOBRIDGEBIO PHARMA INC View history and evidence | $7.47M | 3.34% | 185.14K shares | Prior unavailable — | — | ↗▾ |
| 07 | MACKMERRIMACK PHARMACEUTICALS INCOM NEW View history and evidence | $7.37M | 3.30% | 549.42K shares | Prior unavailable — | — | ↗▾ |
| 08 | MRTXMIRATI THERAPEUTICS INC View history and evidence | $6.34M | 2.84% | 108.00K shares | Prior unavailable — | — | ↗▾ |
| 09 | MRKMERCK & CO. INC. View history and evidence | $5.89M | 2.63% | 54.00K shares | Prior unavailable — | — | ↗▾ |
| 10 | ASNDASCENDIS PHARMA A/SSPONSORED ADR View history and evidence | $5.78M | 2.58% | 45.88K shares | Prior unavailable — | — | ↗▾ |
Options overlay 20
$56.23M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
ALNYALNYLAM PHARMACEUTICALS INC View history and evidence | Put | 228.60K | $43.76M | — | ▾ |
CYTKCYTOKINETICS INCCOM NEW View history and evidence | Call | 73.20K | $6.11M | — | ▾ |
15678U128CEREVEL THERAPEUTICS HOLDING View history and evidence | Put | 50.20K | $2.13M | — | ▾ |
3 / 20 options · preview only
Exited positions 0
No exits reported this quarter.
Every number has a source.
CIK 1940272 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 279822275
}Research all 170 reported holdings.
This page includes 30 of 170 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 170 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1940272","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1940272","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.